Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-027018
Filing Date
2025-09-10
Accepted
2025-09-10 06:32:47
Documents
1
Period of Report
2025-01-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8589
  Complete submission text file 0001641172-25-027018.txt   10037
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Issuer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 829 S. ADAMS ST. VERSAILLES IN 47042
Business Address
Carrico Thomas Joeseph (Reporting) CIK: 0001959325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41775 | Film No.: 251304624